NEWS

Business andBioethics Seminar in Malmö 15-16.10.2006

Assisted Reproduction in the Nordic Countries, A comparative study of policies and regulation By Dr. Riitta Burrell

Legislation on biotechnology
in the Nordic countries - an overview (UPDATED)

MANDATE

MEMBERS

TASKS AND WORKING APPROACHES

ORGANIZED
EVENTS

PUBLICATIONS
AND ORDERING

CONTACT THE COMMITTEE

MAINPAGE

NORDIC VERSION

ENGLISH VERSION

 

Business and bioethics, Clarion Collection Hotel, Malmö, Sweden
15-16 October 2006

PROGRAMME and presentations (pdf)


Sunday 15.10.2006

15.00 Registration and coffee

16.00 Opening
Salla Lötjönen, Chair of the Nordic Committee on Bioethics

16.10-18.30 Session 1. Commercial interests, science and ethics
Chair: Veikko Launis, Member of the Nordic Committee on Bioethics

16.10 The philosophy of biobusiness
Matti Häyry, Professor, University of Manchester

16.40 How does Novo Nordisk address bioethical issues
Lise Holst, Director of Bioethics, Novo Nordisk A/S

17.10 Refreshments

17.30 Genetic databases - private versus public interests
Rainer Kattel, Professor, Tallinn Technical University

18.00 Comments by Jaanus Pikani, Chairman, Estonian Biotechnology Association and Ólöf Ýrr Atladóttir, Managing Director, National Bioethics Committee, Iceland

19.30 Drinks and dinner


Monday 16.10

09.00- 12.00 Session 2. Multiple interests
Chair: Katarina Westerlund, Member of the Nordic Committee on Bioethics

09.00 The ethics and social responsibility in public research funding
Matti Sarvas, Professor Emeritus, Board for Gene Technology

09.30 Private public partnerships
Boo Edgar, Chairman, MedCoast Scandinavia

10.00 From public resources to commercial goods
Aarno Palotie, Professor, Finnish Genome Centre

10.30 Coffee

10.45 Health Diagnostics: To whom, what and why?
William E. Rusconi, Sr. Vice President of Marketing
Myriad Genetics, Inc.

11.15 Combined roles, conflict of interest? Comments by Gunna Christiansen, Professor, University of Aarhus and Tomas Ibsen, Director, Organon

11.45 Discussion

12.00 - 13.00 Lunch

13.00- 15.00 Session 3. Dealing with conflicting interests
Chair: Helena von Troil, Secretary of the Nordic Committee on Bioethics

13.00 Commercial interests versus common goods
Peter Gøtzsche, Director, Nordic Cochrane Centre

13.30 Real new need and economic possibilities
Stina Gestrelius, Deputy CEO, Medicon Valley Academy

14.00 Comments by Dag Helland, Professor, University of Bergen and Eero Vuorio, Chairman, National Board of Research Ethics

Final discussion

14.45 Closing remarks
Salla Lötjönen, Nordic Committee on Bioethics